hycanthone 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 1383 | 3105-97-3 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Potentially toxic, but effective antischistosomal agent, it is a metabolite of LUCANTHONE.
|
Drug dosage:
None
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000871 | Anthelmintics |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000977 | Antiparasitic Agents |
| MeSH PA | D000980 | Antiplatyhelmintic Agents |
| MeSH PA | D012556 | Schistosomicides |
| CHEBI has role | CHEBI:25435 | mutagens |
| CHEBI has role | CHEBI:38941 | schistosomicide drugs |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 13.53 | acidic |
| pKa2 | 8.72 | Basic |
| pKa3 | 3.57 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| DNA-(apurinic or apyrimidinic site) lyase | Enzyme | Kd | 8 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| D00541 | KEGG_DRUG |
| C0020207 | UMLSCUI |
| CHEBI:52768 | CHEBI |
| QHM | PDB_CHEM_ID |
| CHEMBL22077 | ChEMBL_ID |
| DB14061 | DRUGBANK_ID |
| D006826 | MESH_DESCRIPTOR_UI |
| 3634 | PUBCHEM_CID |
| 2207 | INN_ID |
| 2BXX5EVN2A | UNII |
Pharmaceutical products:
None